High-Fat Diet Changed How the Endocannabinoid System Works in the Pancreas and Fat Tissue | Research

The takeaway

Mice on a high-fat diet showed dysregulated endocannabinoid enzyme expression in the pancreas and fat tissue, with increased endocannabinoid levels in the pancreas and decreased levels in subcutaneous fat.

Read this if you're interested in how diet and obesity affect the endocannabinoid system in metabolically important tissues.

Pancreas: endocannabinoids up; subcutaneous fat: endocannabinoids down on high-fat diet

What the researchers found

Researchers fed mice standard or high-fat diets for up to 14 weeks and mapped the endocannabinoid system in their pancreatic and fat tissues.

In the pancreas, they found that CB1 receptors and endocannabinoid-producing enzymes were primarily located in alpha cells (which make glucagon), while degrading enzymes were in beta cells (which make insulin). A high-fat diet caused endocannabinoid-producing enzymes to appear in beta cells and reduced FAAH (a degrading enzyme), resulting in elevated pancreatic endocannabinoid levels.

In subcutaneous fat tissue, the opposite occurred: endocannabinoid levels decreased, with lower expression of producing enzymes and higher expression of FAAH.

Visceral fat showed no diet-induced enzyme changes. Cannabinoid receptor levels remained unchanged in all tissues regardless of diet.

This tissue-specific dysregulation suggests the endocannabinoid system's role in metabolic disease is more complex than simply being "overactive."

Why it matters

Understanding how obesity and high-fat diet alter the endocannabinoid system in metabolically active tissues is essential for developing targeted treatments. The finding that changes are tissue-specific and bidirectional complicates the simple "endocannabinoid overactivity" model of obesity.

The numbers in context

Pancreas: endocannabinoid levels increased on high-fat diet, with enzyme redistribution to beta cells. Subcutaneous fat: endocannabinoid levels decreased. Visceral fat: no enzyme changes. Receptor levels unchanged in all tissues.

How the study worked

Mice were fed standard or high-fat diet for up to 14 weeks. Endocannabinoid system components (CB1, CB2, NAPE-PLD, DAGLalpha, FAAH, MAGL) were mapped in pancreas and adipose tissue by immunohistochemistry. Endocannabinoid levels (2-AG, anandamide) were measured by LC-MS.

What this study cannot tell us

Mouse metabolism differs from human. Only one high-fat diet composition was tested. The functional consequences of enzyme redistribution were not directly tested. Immunohistochemistry provides semi-quantitative data.

How to read the evidence

This is a well-designed animal study with detailed tissue mapping, providing moderate evidence for tissue-specific endocannabinoid dysregulation in diet-induced obesity.

When this study was published

Published in 2008. Research on peripheral endocannabinoid system function in metabolic disease has continued to expand.

The bigger picture

This study revealed that obesity-related endocannabinoid changes are tissue-specific and involve enzyme redistribution, not just overall increases. This complexity explains why blocking CB1 receptors everywhere (as rimonabant does) produces both beneficial metabolic effects and unwanted brain effects.

Questions still open

Could tissue-specific endocannabinoid modulation improve metabolic outcomes without central side effects? Do similar enzyme redistributions occur in human obesity?

Common questions

Why do endocannabinoids increase in the pancreas but decrease in fat?

The body appears to respond to a high-fat diet differently in different tissues. In the pancreas, increased endocannabinoids may affect insulin release. In subcutaneous fat, decreased levels may reflect different regulatory needs. The system is not simply "overactive" everywhere.

Does this explain why cannabis users get the munchies?

Partly. Cannabis activates CB1 receptors throughout the body, including in the pancreas and fat tissue. This study shows the endocannabinoid system is already altered by diet, so the effects of added cannabinoids may depend on metabolic state.

Read the original research

Endocannabinoid dysregulation in the pancreas and adipose tissue of mice fed with a high-fat diet.

Obesity (Silver Spring, Md.), 16(3), 553-65

View on PubMed ↗Publisher’s paper ↗

Citation

Starowicz, Katarzyna M; Cristino, Luigia; Matias, Isabel; Capasso, Raffaele; Racioppi, Alessandro; Izzo, Angelo A; Di Marzo, Vincenzo. (2008). Endocannabinoid dysregulation in the pancreas and adipose tissue of mice fed with a high-fat diet.. Obesity (Silver Spring, Md.), 16(3), 553-65. https://doi.org/10.1038/oby.2007.106